MONOCLONAL
Clinical trials for MONOCLONAL explained in plain language.
Never miss a new study
Get alerted when new MONOCLONAL trials appear
Sign up with your email to follow new studies for MONOCLONAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug budoprutug aims to boost platelets in ITP patients
Disease control Recruiting nowThis study tests a new drug, budoprutug, in 24 adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. The main goal is to check safety and find the right dose, while also seeing if it helps raise platelet counts.…
Matched conditions: MONOCLONAL
Phase: PHASE1, PHASE2 • Sponsor: Climb Bio, Inc. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Scientists seek mast cells to unlock disease secrets
Knowledge-focused Recruiting nowThis study aims to collect mast cells from people with mastocytosis to understand what makes these cells grow and survive. Up to 600 participants aged 2 to 80 will provide blood and bone marrow samples during a single 8-hour visit. No treatment is given; the goal is to learn more…
Matched conditions: MONOCLONAL
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 26, 2026 03:17 UTC